ARISTADA ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882 MG/3.2ML INTRAMUSCULAR Claim will pay automatically for ARISTADA if enrollee has a paid claim for at least a 1 days supply of oral aripiprazole or ABILIFY MAINTENA AND LATUDA in the past. Otherwise, ARISTADA requires a step therapy exception request indicating: (1) history of inadequate treatment response with oral aripiprazole or ABILIFY MAINTENA AND LATUDA, OR (2) oral aripiprazole was previously tolerated but there is a history of adverse event with ABILIFY MAINTENA and LATUDA, OR (3) oral aripiprazole was previously tolerated but ABILIFY MAINTENA and LATUDA are contraindicated. 1
MYRBETRIQ MYRBETRIQ TABLET EXTENDED RELEASE 24 HOUR 25 MG ORAL MYRBETRIQ TABLET EXTENDED RELEASE 24 HOUR 50 MG ORAL Claim will pay automatically for Myrbetriq if enrollee has a paid claim for at least a 1 days supply of any formulary urinary anticholinergic in the past. Otherwise, Myrbetriq requires a step therapy exception request indicating: (1) history of inadequate treatment response with formulary urinary anticholinergic, OR (2) history of adverse event with formulary urinary anticholinergic, OR (3) formulary urinary anticholinergic is contraindicated. 2
PANCREATIC ENZYMES CREON CAPSULE DELAYED RELEASE PARTICLES 12000 UNIT ORAL CREON CAPSULE DELAYED RELEASE PARTICLES 24000 UNIT ORAL CREON CAPSULE DELAYED RELEASE PARTICLES 3000-9500 UNIT ORAL CREON CAPSULE DELAYED RELEASE PARTICLES 36000 UNIT ORAL CREON CAPSULE DELAYED RELEASE PARTICLES 6000 UNIT ORAL 1. The patient is currently stabilized on Creon OR 2. The patient has had a trial of Zenpep or Pancreaze OR 3. The patient has had an inadequate response after a trial of Zenpep or Pancreaze OR 4. The patient is intolerant to or had an adverse reaction with Zenpep or Pancreaze. 3
PPI DEXILANT CAPSULE DELAYED RELEASE 30 MG ORAL DEXILANT CAPSULE DELAYED RELEASE 60 MG ORAL Claim will pay automatically for Dexilant if enrollee has a paid claim for at least a 1 days supply of lansoprazole, omeprazole, pantoprazole, or rabeprazole in the past. Otherwise, Dexilant requires a step therapy exception request indicating: (1) history of inadequate treatment response with lansoprazole, omeprazole, pantoprazole, or rabeprazole, OR (2) history of adverse event with lansoprazole, omeprazole, pantoprazole, or rabeprazole, OR (3) lansoprazole, omeprazole, pantoprazole, or rabeprazole is contraindicated. 4
RHEUMATOID ARTHRITIS ACTEMRA SOLUTION 200 MG/10ML INTRAVENOUS ACTEMRA SOLUTION 400 MG/20ML INTRAVENOUS ACTEMRA SOLUTION 80 MG/4ML INTRAVENOUS ACTEMRA SOLUTION PREFILLED SYRINGE 162 MG/0.9ML CIMZIA KIT 2 X 200 MG CIMZIA PREFILLED KIT 2 X 200 MG/ML COSENTYX SENSOREADY PEN SOLUTION AUTO-INJECTOR 150 MG/ML COSENTYX SOLUTION PREFILLED SYRINGE 150 MG/ML KINERET SOLUTION PREFILLED SYRINGE 100 MG/0.67ML ORENCIA CLICKJECT SOLUTION AUTO-INJECTOR 125 MG/ML ORENCIA SOLUTION PREFILLED SYRINGE 125 MG/ML ORENCIA SOLUTION PREFILLED SYRINGE 50 MG/0.4ML ORENCIA SOLUTION PREFILLED SYRINGE 87.5 MG/0.7ML ORENCIA SOLUTION RECONSTITUTED 250 MG INTRAVENOUS SIMPONI ARIA SOLUTION 50 MG/4ML INTRAVENOUS SIMPONI SOLUTION AUTO- INJECTOR 100 MG/ML SIMPONI SOLUTION AUTO- INJECTOR 50 MG/0.5ML SIMPONI SOLUTION PREFILLED SYRINGE 100 MG/ML SIMPONI SOLUTION PREFILLED SYRINGE 50 MG/0.5ML STELARA SOLUTION 130 MG/26ML INTRAVENOUS STELARA SOLUTION PREFILLED SYRINGE 45 MG/0.5ML STELARA SOLUTION PREFILLED SYRINGE 90 MG/ML XELJANZ TABLET 5 MG ORAL 5
Claim will pay automatically for Actrema, Cimzia, Cosentyx, Kineret, Orencia, Simponi, Stelara, or Xeljanz if enrollee has a paid claim for at least a 1 days supply of Enbrel or Humira in the past. Otherwise, Actrema, Cimzia, Cosentyx, Kineret, Orencia, Simponi, Stelara, or Xeljanz requires a step therapy exception request indicating: (1) history of inadequate treatment response with Enbrel or Humira, OR (2) history of adverse event with Enbrel or Humira, OR (3) Enbrel or Humira is contraindicated, OR (4) For diagnosis cryopyrin-associated periodic syndromes, Kineret will be approved. 6
TRINTELLIX TRINTELLIX TABLET 10 MG ORAL TRINTELLIX TABLET 20 MG ORAL TRINTELLIX TABLET 5 MG ORAL Claim will pay automatically for trintellix if enrollee has a paid claim for at least a 1 days supply of any 2 generic formulary antidepressants in the past. Otherwise, trintellix requires a step therapy exception request indicating: (1) history of inadequate treatment response with any 2 generic formulary antidepressants, OR (2) history of adverse event with any 2 generic formulary antidepressantss, OR (3) any 2 generic formulary antidepressants are contraindicated. 7
UCERIS UCERIS FOAM 2 MG/ACT RECTAL UCERIS TABLET EXTENDED RELEASE 24 HOUR 9 MG ORAL Claim will pay automatically for Uceris if enrollee has a paid claim for at least a 1 days supply of any formulary corticosteroid used to treat ulcerative colitis in the past. Otherwise, Uceris requires a step therapy exception request indicating: (1) history of inadequate treatment response with formulary corticosteroid used to treat ulcerative colitis, OR (2) history of adverse event with formulary corticosteroid used to treat ulcerative colitis, OR (3) formulary corticosteroid used to treat ulcerative colitis is contraindicated. 8
VRAYLAR VRAYLAR CAPSULE 1.5 MG ORAL VRAYLAR CAPSULE 3 MG ORAL VRAYLAR CAPSULE 4.5 MG ORAL VRAYLAR CAPSULE 6 MG ORAL VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG ORAL Claim will pay automatically for VRAYLAR if enrollee has a paid claim for at least a 1 days supply of ARIPIPRAZOLE, OLANZAPINE, QUETIAPINE, QUITIAPINE ER, RISPERIDONE, ZIPRASIDONE OR LATUDA in the past 365 days. Otherwise, Vraylar requires a step therapy exception request indicating any ONE of criteria 1,2,3, OR 4: (1) history of inadequate treatment response with ARIPIPRAZOLE, OLANZAPINE, QUETIAPINE, QUITIAPINE ER, RISPERIDONE, ZIPRASIDONE, or LATUDA OR (2) history of adverse event with ARIPIPRAZOLE, OLANZAPINE, QUETIAPINE, QUITIAPINE ER, RISPERIDONE, ZIPRASIDONE, or LATUDA OR (3) ARIPIPRAZOLE, OLANZAPINE, QUETIAPINE, QUITIAPINE ER, RISPERIDONE, ZIPRASIDONE or LATUDA are contraindicated. OR (4) FOR Diagnosis OF MANIC EPIPISODES ASSOCIATED WTIH BIPOLAR DISORDER, THE COVERAGE DETERMINATION WILL BE APPROVED WITHOUT REQUIREMENT OF TRIAL AND FAILURE OR CONTRAINDICATION TO LATUDA. 9
XTANDI XTANDI CAPSULE 40 MG ORAL Claim will pay automatically for Xtandi if enrollee has a paid claim for at least a 1 days supply of Zytiga in the past. Otherwise, Xtandi requires a step therapy exception request indicating: (1) history of inadequate treatment response with Zytiga, OR (2) history of adverse event with Zytiga, OR (3) Zytiga is contraindicated. 10
Alphabetical Listing A ACTEMRA SOLUTION 200 MG/10ML INTRAVENOUS... 5, 6 ACTEMRA SOLUTION 400 MG/20ML INTRAVENOUS... 5, 6 ACTEMRA SOLUTION 80 MG/4ML INTRAVENOUS... 5, 6 ACTEMRA SOLUTION PREFILLED SYRINGE 162 MG/0.9ML... 5, 6 ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR... 1 ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR... 1 ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR... 1 ARISTADA PREFILLED SYRINGE 882 MG/3.2ML INTRAMUSCULAR... 1 C CIMZIA KIT 2 X 200 MG... 5, 6 CIMZIA PREFILLED KIT 2 X 200 MG/ML... 5, 6 COSENTYX SENSOREADY PEN SOLUTION AUTO-INJECTOR 150 MG/ML... 5, 6 COSENTYX SOLUTION PREFILLED SYRINGE 150 MG/ML... 5, 6 CREON CAPSULE DELAYED RELEASE PARTICLES 12000 UNIT ORAL... 3 CREON CAPSULE DELAYED RELEASE PARTICLES 24000 UNIT ORAL... 3 CREON CAPSULE DELAYED RELEASE PARTICLES 3000-9500 UNIT ORAL.. 3 CREON CAPSULE DELAYED RELEASE PARTICLES 36000 UNIT ORAL... 3 CREON CAPSULE DELAYED RELEASE PARTICLES 6000 UNIT ORAL... 3 D DEXILANT CAPSULE DELAYED RELEASE 30 MG ORAL... 4 DEXILANT CAPSULE DELAYED RELEASE 60 MG ORAL... 4 K KINERET SOLUTION PREFILLED SYRINGE 100 MG/0.67ML... 5, 6 M MYRBETRIQ TABLET EXTENDED RELEASE 24 HOUR 25 MG ORAL... 2 MYRBETRIQ TABLET EXTENDED RELEASE 24 HOUR 50 MG ORAL... 2 O ORENCIA CLICKJECT SOLUTION AUTO-INJECTOR 125 MG/ML... 5, 6 ORENCIA SOLUTION PREFILLED SYRINGE 125 MG/ML... 5, 6 ORENCIA SOLUTION PREFILLED SYRINGE 50 MG/0.4ML... 5, 6 ORENCIA SOLUTION PREFILLED SYRINGE 87.5 MG/0.7ML... 5, 6 ORENCIA SOLUTION RECONSTITUTED 250 MG INTRAVENOUS... 5, 6 S SIMPONI ARIA SOLUTION 50 MG/4ML INTRAVENOUS... 5, 6 SIMPONI SOLUTION AUTO-INJECTOR 100 MG/ML... 5, 6 SIMPONI SOLUTION AUTO-INJECTOR 50 MG/0.5ML... 5, 6 SIMPONI SOLUTION PREFILLED SYRINGE 100 MG/ML... 5, 6 SIMPONI SOLUTION PREFILLED SYRINGE 50 MG/0.5ML... 5, 6 STELARA SOLUTION 130 MG/26ML INTRAVENOUS... 5, 6 11
STELARA SOLUTION PREFILLED SYRINGE 45 MG/0.5ML... 5, 6 STELARA SOLUTION PREFILLED SYRINGE 90 MG/ML... 5, 6 T TRINTELLIX TABLET 10 MG ORAL... 7 TRINTELLIX TABLET 20 MG ORAL... 7 TRINTELLIX TABLET 5 MG ORAL... 7 U UCERIS FOAM 2 MG/ACT RECTAL... 8 UCERIS TABLET EXTENDED RELEASE 24 HOUR 9 MG ORAL... 8 V VRAYLAR CAPSULE 1.5 MG ORAL... 9 VRAYLAR CAPSULE 3 MG ORAL... 9 VRAYLAR CAPSULE 4.5 MG ORAL... 9 VRAYLAR CAPSULE 6 MG ORAL... 9 VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG ORAL... 9 X XELJANZ TABLET 5 MG ORAL... 5, 6 XTANDI CAPSULE 40 MG ORAL... 10 12